Table of Contents
This comprehensive research evaluates the Romanian pharmaceutical distribution market on main segments: generic and patented medicine, prescribed and without prescription, medical equipment and retail. In order to understand the developments that took place on the Romanian market between 2008-2013 in the first chapter of the research is analyzed the evolution of the global market and its outlook. For international market are provided historical data for 2008 to 2013 and forecast for 2015-2018. Also there are financial data of the main players and a comparative analysis of macroeconomic indicators at regional level (S-E Europe).
The brief analysis of the Romanian macroeconomic framework is the starting point for evaluating and estimating the domestic pharmaceutical distribution market. For each segment are presentend: the evolution between 2008-2013; the features of the market and is made a top 10 of the most important players on the market. Each player is presented in the study and there are provided financial data and indicators for a six year period.
For deepening the research on Romanian pharmaceutical distribution market is made an analysis on NACE codes based on total values at macroeconomic level (total companies that have registered this activity as core business). It is a thorough review where financial indicators such as turnover, net profit, total debt/total assets, total number of companies, number of companies with losses / profits, number of employees, net profit margin are calculated and interpreted for 2008-2013.
In order to support foreign companies planning to enter the Romanian market in the study there were conducted the following types of analyzes: Porter Analysis, PEST Analysis and Value Chain Analysis. Also are listed the most important factors that influence the activity of a market player and recommendations for the management of companies in the sector.
Information and data on pharmaceutical distribution market were obtained from a variety of sources: European Federation of Pharmaceutical Industries and Associations, Ministry of Health, National Institute of Statistics, National Commission for Prognosis, National Bank of Romania, the National Trade Register Office, Ministry of Finance.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...